Genenta Science SPA
GNTA1.450USD
-0.030-2.03%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
27.76MMarket Cap
LossP/E TTM
More Details of Genenta Science SPA Company
Genenta Science SpA is an Italy-based company engaged in clinical-stage biotechnology research. The Company focuses on the development of lentivirus-based gene and cell therapies in cancer. It uses gene-based cytokine delivery to activate the immune system within the tumor providing the anti-tumor response. The Company not only operates locally but also is present in global markets, including the United States.
Genenta Science SPA Info
Ticker SymbolGNTA
Company nameGenenta Science SPA
IPO dateDec 15, 2021
CEOParacchi (Pierluigi)
Number of employees13
Security typeDepository Receipt
Fiscal year-endDec 15
AddressVia Olgettina 58
CityMILANO
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryItaly
Postal code20132
Phone
Websitehttps://www.genenta.com/
Ticker SymbolGNTA
IPO dateDec 15, 2021
CEOParacchi (Pierluigi)
Company Executives of Genenta Science SPA
Name
Name/Position
Position
Shareholding
Change
Mr. Pierluigi Paracchi
Mr. Pierluigi Paracchi
Chairman of the Board, Chief Executive Officer, General Manager
Chairman of the Board, Chief Executive Officer, General Manager
2.30M
-0.13%
Dr. Carlo Russo, M.D.
Dr. Carlo Russo, M.D.
Chief Medical Officer, Head of Development
Chief Medical Officer, Head of Development
602.42K
+0.67%
Mr. Richard B. Slansky
Mr. Richard B. Slansky
Chief Financial Officer
Chief Financial Officer
22.15K
+11.03%
Dr. Armon Reza Sharei, Ph.D.
Dr. Armon Reza Sharei, Ph.D.
Independent Director
Independent Director
--
--
Dr. Todd Wider, M.D.
Dr. Todd Wider, M.D.
Independent Director
Independent Director
--
--
Ms. Barbara Regonini
Ms. Barbara Regonini
Finance Director
Finance Director
--
-100.00%
Dr. Stefania Mazzoleni, Ph.D.
Dr. Stefania Mazzoleni, Ph.D.
Scientific Project Manager, Communication Officer
Scientific Project Manager, Communication Officer
--
--
Dr. Lauren Haeyong Chung, Ph.D.
Dr. Lauren Haeyong Chung, Ph.D.
Independent Director
Independent Director
--
--
Dr. John Louis Cantello, Ph.D.
Dr. John Louis Cantello, Ph.D.
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Pierluigi Paracchi
Mr. Pierluigi Paracchi
Chairman of the Board, Chief Executive Officer, General Manager
Chairman of the Board, Chief Executive Officer, General Manager
2.30M
-0.13%
Dr. Carlo Russo, M.D.
Dr. Carlo Russo, M.D.
Chief Medical Officer, Head of Development
Chief Medical Officer, Head of Development
602.42K
+0.67%
Mr. Richard B. Slansky
Mr. Richard B. Slansky
Chief Financial Officer
Chief Financial Officer
22.15K
+11.03%
Dr. Armon Reza Sharei, Ph.D.
Dr. Armon Reza Sharei, Ph.D.
Independent Director
Independent Director
--
--
Dr. Todd Wider, M.D.
Dr. Todd Wider, M.D.
Independent Director
Independent Director
--
--
Ms. Barbara Regonini
Ms. Barbara Regonini
Finance Director
Finance Director
--
-100.00%
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Mon, Nov 17
Updated: Mon, Nov 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Paracchi (Pierluigi)
11.99%
IRCCS Ospedale San Raffaele
9.91%
Naldini (Luigi M.D., Ph.D.)
7.24%
Gentner (Bernard)
3.62%
Russo (Carlo)
3.15%
Other
64.10%
Shareholders
Shareholders
Proportion
Paracchi (Pierluigi)
11.99%
IRCCS Ospedale San Raffaele
9.91%
Naldini (Luigi M.D., Ph.D.)
7.24%
Gentner (Bernard)
3.62%
Russo (Carlo)
3.15%
Other
64.10%
Shareholder Types
Shareholders
Proportion
Individual Investor
26.27%
Corporation
9.91%
Investment Advisor
5.58%
Investment Advisor/Hedge Fund
2.21%
Sovereign Wealth Fund
1.63%
Holding Company
1.22%
Hedge Fund
0.59%
Bank and Trust
0.02%
Research Firm
0.01%
Other
52.57%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
16
1.96M
10.22%
-334.32K
2025Q2
24
9.06M
49.52%
-260.05K
2025Q1
28
9.12M
49.85%
-26.40K
2024Q4
28
8.70M
47.57%
-293.74K
2024Q3
26
8.60M
47.05%
-368.88K
2024Q2
26
8.48M
46.40%
-155.29K
2024Q1
25
8.51M
46.63%
+417.20K
2023Q4
25
8.38M
45.98%
+434.51K
2023Q3
24
8.11M
44.52%
+167.75K
2023Q2
24
8.11M
44.52%
+601.69K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Paracchi (Pierluigi)
2.30M
12.55%
-3.10K
-0.13%
Mar 26, 2025
IRCCS Ospedale San Raffaele
1.90M
10.37%
--
--
Mar 26, 2025
Naldini (Luigi M.D., Ph.D.)
1.39M
7.58%
--
--
Mar 26, 2025
Gentner (Bernard)
692.87K
3.79%
--
--
Mar 26, 2025
Russo (Carlo)
602.42K
3.29%
+4.00K
+0.67%
Mar 26, 2025
Eurizon Capital SGR S.p.A.
360.00K
1.97%
--
--
Aug 31, 2025
Kairos Partners SGR S.p.A.
335.61K
1.83%
-24.00
-0.01%
Jun 30, 2025
Norges Bank Investment Management (NBIM)
311.74K
1.7%
+18.91K
+6.46%
Jun 30, 2025
Investitori SGR S.p.A.
234.05K
1.28%
--
--
Aug 31, 2025
Allianz SE
234.05K
1.28%
+500.00
+0.21%
Jun 30, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Genenta Science SPA?
The top five shareholders of Genenta Science SPA are:
Paracchi (Pierluigi) holds 2.30M shares, accounting for 12.55% of the total shares.
IRCCS Ospedale San Raffaele holds 1.90M shares, accounting for 10.37% of the total shares.
Naldini (Luigi M.D., Ph.D.) holds 1.39M shares, accounting for 7.58% of the total shares.
Gentner (Bernard) holds 692.87K shares, accounting for 3.79% of the total shares.
Russo (Carlo) holds 602.42K shares, accounting for 3.29% of the total shares.
Paracchi (Pierluigi) holds 2.30M shares, accounting for 12.55% of the total shares.
IRCCS Ospedale San Raffaele holds 1.90M shares, accounting for 10.37% of the total shares.
Naldini (Luigi M.D., Ph.D.) holds 1.39M shares, accounting for 7.58% of the total shares.
Gentner (Bernard) holds 692.87K shares, accounting for 3.79% of the total shares.
Russo (Carlo) holds 602.42K shares, accounting for 3.29% of the total shares.
What are the top three shareholder types of Genenta Science SPA?
The top three shareholder types of Genenta Science SPA are:
Paracchi (Pierluigi)
IRCCS Ospedale San Raffaele
Naldini (Luigi M.D., Ph.D.)
Paracchi (Pierluigi)
IRCCS Ospedale San Raffaele
Naldini (Luigi M.D., Ph.D.)
How many institutions hold shares of Genenta Science SPA (GNTA)?
As of 2025Q3, 16 institutions hold shares of Genenta Science SPA, with a combined market value of approximately 1.96M, accounting for 10.22% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -39.30%.
What is the biggest source of revenue for Genenta Science SPA?
In --, the -- business generated the highest revenue for Genenta Science SPA, amounting to -- and accounting for --% of total revenue.
